Joshua Schimmer


Piper Jaffray Confident Aptevo Therapeutics Inc (APVO) Is Back on Track; Shares Soar 14%

Aptevo Therapeutics Inc (NASDAQ:APVO) shares are ascending 14% after the biotech firm announced that its Factor 9 replacement therapy IXINITY manufacturing activity is …

Piper Jaffray Moves to the Sidelines and Slashes Price Target on Inotek Pharmaceuticals Corp (ITEK); Shares Crash 70%

Inotek Pharmaceuticals Corp (NASDAQ:ITEK) shares are on a rapid 70% descent after the firm announced top-line results this morning from the Phase 3 …

Piper Jaffray Bullish on GW Pharmaceuticals PLC- ADR (GWPH) Following New AES Data

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) shares are on a 6% ascent today after the biotech firm presented additional Epidiolex data from the first …

Gilead Sciences, Inc. (GILD) Continues to Shine as Piper Jaffray’s Top Large Cap Pick

Piper Jaffray Joshua Schimmer is out with a research report on Gilead Sciences, Inc. (NASDAQ:GILD) after hosting an investor dinner with the biotech …

Piper Jaffray Healthcare Conference Review: Gilead Sciences, Inc. (GILD), GW Pharmaceuticals PLC- ADR (GWPH)

Joshua Schimmer at Piper Jaffray is chiming in on two biotech players, Gilead Sciences, Inc. (NASDAQ:GILD) and GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), in …

Piper Jaffray Confident On bluebird bio Inc (BLUE) After Hosting Investor Meeting With Management

Yesterday, Piper Jaffray analyst Joshua Schimmer hosted an investor dinner with bluebird bio Inc (NASDAQ:BLUE) management ahead of his healthcare conference. Following the …

Piper Jaffray Weighs in on Gilead Sciences, Inc. (GILD) Following Two Phase 3 Studies Results Evaluating Momelotinib for Patients With Myelofibrosis

Yesterday evening, Gilead Sciences, Inc. (NASDAQ:GILD) announced top-line results from both of its Phase 3 trials of momelotinib, an examinational inhibitor of Janus …

Piper Jaffray Sings the Praises of Ionis Pharmaceuticals Inc (IONS) as a Top Mid-Cap Pick Following Management Meetings

Last week, Piper Jaffray analyst Joshua Schimmer hosted Richard Geary, Senior Vice President (SVP) of Ionis Pharmaceuticals Inc (NASDAQ:IONS), as well as Wade …

Piper Jaffray Shares Two Cents on Gilead Sciences, Inc. (GILD) Clinical Updates

This morning, Gilead Sciences, Inc. (NASDAQ:GILD) announced it is advancing GS-4997 (selonsertib), an investigational inhibitor of apoptosis signal-regulating kinase 1 (ASK1), in nonalcoholic …

What Analysts Are Saying About These Two Falling Stocks: Rigel Pharmaceuticals, Inc. (RIGL), DXP Enterprises Inc (DXPE)

Piper Jaffray and William Blair are joining the conversation on falling stocks Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) and DXP Enterprises Inc (NASDAQ:DXPE) after volatile news has …